Point and Trend Accuracy of a Continuous Glucose Measurement System using Intravenous Microdialysis in Critically Ill Patients

Point and Trend Accuracy of a Continuous Glucose Measurement System using Intravenous Microdialysis in Critically Ill Patients - ACSI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41459

Enrollment

Registered

2014-03-07

Start date

2014-05-13

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical illness-associated hyperglycemia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: At least 18 years old; Arterial catheter needed for standard care and present; Central venous catheter needed for standard care; Admitted to the ICU; and Expected to stay in the ICU for at least 48 hours.

Exclusion criteria

Exclusion criteria: Currently participating in another investigational drug or device study Known pregnancy.

Design outcomes

Primary

Measure	Time frame
The main study parameter is point accuracy of continuous glucose monitoring* measurements as compared to current arterial blood glucose measurements.	—

Secondary

Measure	Time frame
Other study parameters include trend accuracy and reliability of the system.	—

Countries

Netherlands

Outcome results